GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,596,000 | -1.9% | 702,379 | -0.7% | 0.50% | +8.4% |
| Q4 2021 | $31,195,000 | +14.5% | 707,380 | -0.8% | 0.46% | +11.2% |
| Q3 2021 | $27,253,000 | -4.3% | 713,247 | -0.3% | 0.42% | -2.3% |
| Q2 2021 | $28,480,000 | -2.5% | 715,215 | -12.6% | 0.43% | -8.5% |
| Q1 2021 | $29,220,000 | -2.5% | 818,718 | +0.6% | 0.47% | -7.7% |
| Q4 2020 | $29,955,000 | -7.1% | 814,006 | -5.0% | 0.51% | -19.8% |
| Q3 2020 | $32,256,000 | -8.7% | 856,948 | -1.1% | 0.63% | -11.2% |
| Q2 2020 | $35,329,000 | +7.8% | 866,118 | +0.2% | 0.71% | -8.4% |
| Q1 2020 | $32,759,000 | -21.2% | 864,574 | -2.3% | 0.78% | +5.9% |
| Q4 2019 | $41,579,000 | -3.6% | 884,843 | -12.4% | 0.73% | -6.4% |
| Q3 2019 | $43,116,000 | +5.9% | 1,010,208 | -0.7% | 0.78% | +9.2% |
| Q2 2019 | $40,699,000 | -3.8% | 1,016,958 | +0.4% | 0.72% | -5.5% |
| Q1 2019 | $42,313,000 | -0.9% | 1,012,513 | -9.4% | 0.76% | -10.9% |
| Q4 2018 | $42,701,000 | -5.6% | 1,117,525 | -0.8% | 0.85% | +18.6% |
| Q3 2018 | $45,241,000 | -0.2% | 1,126,240 | +0.2% | 0.72% | -5.4% |
| Q2 2018 | $45,313,000 | +3.4% | 1,124,121 | +0.3% | 0.76% | +1.3% |
| Q1 2018 | $43,807,000 | +13.4% | 1,121,240 | +3.0% | 0.75% | +14.2% |
| Q4 2017 | $38,620,000 | -19.0% | 1,088,795 | -7.3% | 0.66% | -21.0% |
| Q3 2017 | $47,682,000 | -8.4% | 1,174,429 | -2.7% | 0.83% | -8.7% |
| Q2 2017 | $52,042,000 | -0.2% | 1,206,919 | -2.4% | 0.91% | -1.8% |
| Q1 2017 | $52,146,000 | +11.2% | 1,236,857 | +1.6% | 0.93% | +5.6% |
| Q4 2016 | $46,900,000 | -11.7% | 1,217,865 | -1.1% | 0.88% | -7.9% |
| Q3 2016 | $53,126,000 | +0.3% | 1,231,775 | +0.7% | 0.95% | -0.5% |
| Q2 2016 | $52,991,000 | +8.4% | 1,222,675 | +1.4% | 0.96% | +14.2% |
| Q1 2016 | $48,896,000 | +1.6% | 1,205,820 | +1.1% | 0.84% | +6.6% |
| Q4 2015 | $48,123,000 | +5.1% | 1,192,629 | +0.2% | 0.79% | +8.4% |
| Q3 2015 | $45,783,000 | -3.5% | 1,190,709 | +4.5% | 0.73% | +13.1% |
| Q2 2015 | $47,467,000 | -8.8% | 1,139,664 | +1.0% | 0.64% | +2.2% |
| Q1 2015 | $52,061,000 | +10.0% | 1,128,075 | +1.9% | 0.63% | +13.9% |
| Q4 2014 | $47,316,000 | +6.7% | 1,107,070 | +14.8% | 0.55% | +8.7% |
| Q3 2014 | $44,349,000 | -1.9% | 964,730 | +14.1% | 0.51% | +4.7% |
| Q2 2014 | $45,222,000 | +1.5% | 845,595 | +1.4% | 0.48% | +2.8% |
| Q1 2014 | $44,539,000 | +2.2% | 833,590 | +2.1% | 0.47% | +1.3% |
| Q4 2013 | $43,576,000 | +7.5% | 816,190 | +1.0% | 0.47% | -1.7% |
| Q3 2013 | $40,530,000 | +0.3% | 807,860 | -0.1% | 0.47% | -10.4% |
| Q2 2013 | $40,401,000 | – | 808,510 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |